The Media Sabotage of Hydroxychloroquine Use for COVID-19: Doctors Worldwide Protest the Disaster – Global Research

the-media-sabotage-of-hydroxychloroquine-use-for-covid-19:-doctors-worldwide-protest-the-disaster-–-global-research

03-07-20 06:23:00,

Introduction

A dangerous, life-threatening sequence of events has unfolded since The Lancet’s fraudulent[i] hydroxychlorquine (HCQ) article appeared May 22, followed by headlines demonizing this ancient anti-malarial drug – aka quinine, aka chloroquine, and known to antiquity as the “sacred bark”.[ii]

The false news that 96,032 hospitalized patients on six continents were at risk for lethal heart rhythms sent shock waves throughout the world. Immediately, many randomized control trials (RCT’s) at the World Health Organization and elsewhere were suspended until the Lancet article was finally retracted two weeks later, June 5.

But the damage was done. The WHO had ordered countries to stop using it, and European Union countries had banned its use (outside clinical trials) for Covid-19 treatment.  Clinical trials themselves, such as the NAID trial announced by the US National Institutes of Health on May 14,[iii] were cancelled.  A hostile press frightened people from re-entering clinical trials that might have cleared it for use.

Worst of all, newly symptomatic people who had formerly benefitted from early outpatient treatment were now progressing to Phase 2 of the disease, during which the dangerous immune system “cytokine” storm[iv] often leads to hospitalization and death.

On May 27, less than a week into this disaster, a top world epidemiology journal, the American Journal of Epidemiology, issued an urgent call from award-winning Yale Professor, Harvey Risch: “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.”

The abstract reads:

“Hydroxychloroquine+azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September. Early outpatient illness is very different than later hospitalized florid disease and the treatments differ. Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of the pair in early high-risk outpatient disease. Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy…These medications need to be widely available and promoted immediately for physicians to prescribe.”(author’s bolding)[v]

A Google News search reveals the astonishing truth that the corporate media, with the exception of Fox News,[vi] did not report this article.

Is the media interested in a cure for Covid-19? 

 » Lees verder

%d bloggers liken dit: